Reports on the acquisition of drug safety specialist Lincoln Technologies by Phase Forward. Amount of the acquisition deal; Function of Lincoln Technologies under the terms of the deal; Significance of the Clinical Data Interchange Standards Consortium standards capabilities of Lincoln to the company.